Sickle Cell Disease Association of America promotes clinical trials
HANOVER, Md.—The Sickle Cell Disease Association of America, a national nonprofit membership organization that advocates for people affected by sickle cell, formed the Sickle Cell Disease C.A.R.E.S. Consortium, an initiative of pharmaceutical companies united to promote clinical trial participation and education. “We have an opportunity and a responsibility to change the perception of clinical trials…